Description: Respiri Limited, formerly Isonea Limited, is engaged in the research, development and commercialization of medical devices, and the production of mobile health applications. The Company's segments include Australia and Israel. The Australia segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Israel. The Company's devices and applications use digital wheeze detection and measurement technology. The Company's acoustic respiratory monitoring (ARM) technology records airway sounds to detect continuous adventitious breath sounds (CABS), and measures the extent of wheezing caused by airway obstruction. The Company's products include AirSonea, SonoSentry, Wholter and PulmoTrack Computerised Wheeze Detection.
Home Page: respiri.co
RSH Technical Analysis
432 St Kilda Road
Melbourne,
VIC
3004
Australia
Phone:
61 3 9653 9160
Officers
| Name | Title |
|---|---|
| Mr. Nicholas Smedley | Exec. Chairman |
| Mr. Marjan Mikel B.Sc., M.A.I.C.D. | CEO, MD & Exec. Director |
| Mr. George Vlachodimitropoulos | Chief Technology Officer |
| Mr. Theo Antonopoulos | Chief Commercial Officer |
| Mr. Andrew Metcalfe CPA | Company Sec. |
| Prof. Noam Gavriely | Medical & Scientific Advisor |
| Mr. Simon Godfrey | Medical & Scientific Advisor |
| Mr. Philippe Ludekens | Gen. Mang. of Commercial Operations |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 10.9219 |
| Price-to-Sales TTM: | 44.6171 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |